Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Efficacy of the Bi-Aspheric Monofocal IOL

NCT: NCT06380478 · COMPLETED

NCT IDNCT06380478
StatusCOMPLETED
Start Date2024-03-05
Completion2025-08-19

Brief Summary

This is an observational, single-center, non-control, open-label post-marketing study. Patients implanted with an aspicio™ Monofocal Intraocular Lens will be scheduled for a follow-up visit at least 3 months after the surgery to undergo a routine basic ophthalmological examination.

Frequently Asked Questions

What is Safety and Efficacy of the Bi-Aspheric Monofocal IOL?

Safety and Efficacy of the Bi-Aspheric Monofocal IOL is a clinical trial registered under NCT06380478. Current status: COMPLETED.

What is the status of NCT06380478?

The current status of NCT06380478 (Safety and Efficacy of the Bi-Aspheric Monofocal IOL) is: COMPLETED.

When did Safety and Efficacy of the Bi-Aspheric Monofocal IOL start?

Safety and Efficacy of the Bi-Aspheric Monofocal IOL started on 2024-03-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑